Amino acid metabolism

Amino acid metabolism encompasses the integrated biochemical pathways that govern the synthesis, interconversion, and catabolism of the twenty proteinogenic amino acids, coordinating nitrogen handling, carbon skeleton utilization, and the production of nucleotides, neurotransmitters, and other nitrogen-containing biomolecules.¹

Biological context and functional relevance

Amino acids occupy a central position in cellular metabolism, serving simultaneously as building blocks for protein synthesis, substrates for energy production, precursors for biosynthesis, and signaling molecules that regulate growth and stress responses. Their metabolism links carbohydrate and lipid pathways through shared intermediates of the tricarboxylic acid (TCA) cycle and glycolysis, allowing flexible reallocation of carbon and nitrogen according to physiological demand.²

Beyond their structural role, amino acids drive one-carbon metabolism, redox balance through glutathione synthesis, and neurotransmission via glutamate, gamma-aminobutyric acid (GABA), and monoamines. Disruption of amino acid handling underlies inborn errors of metabolism, contributes to insulin resistance, and supports the metabolic reprogramming that sustains tumor growth and immune cell function.³

Classification and nutritional framework

The twenty proteinogenic amino acids are classified by the body's capacity for de novo synthesis. Essential amino acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine) cannot be synthesized in mammals and must be obtained from the diet. Non-essential amino acids are synthesized from glycolytic and TCA cycle intermediates, while conditionally essential amino acids, such as arginine and glutamine, become indispensable during growth, stress, or illness.⁴

A complementary classification groups amino acids by their catabolic fate. Glucogenic amino acids yield pyruvate or TCA intermediates that feed gluconeogenesis, ketogenic amino acids generate acetyl-CoA or acetoacetate, and several amino acids, including isoleucine, phenylalanine, threonine, tryptophan, and tyrosine, are both. This functional taxonomy explains how amino acid catabolism integrates with whole-body fuel homeostasis.

Nitrogen at the center of amino acid metabolism

Transamination and the glutamate hub

Amino acid catabolism begins with removal of the α-amino group, predominantly through transamination. Aminotransferases, using pyridoxal 5′-phosphate (PLP) as cofactor, transfer amino groups onto α-ketoglutarate to generate glutamate. Glutamate thus functions as a central collection point for nitrogen derived from most amino acids, channeling it toward either biosynthesis or disposal.⁵

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) illustrate the system's logic: ALT couples pyruvate to alanine in muscle, enabling the alanine cycle that delivers nitrogen and gluconeogenic carbon to the liver, while AST generates aspartate, a nitrogen donor for the urea cycle and nucleotide synthesis.

Oxidative deamination and ammonia liberation

Glutamate is oxidatively deaminated by glutamate dehydrogenase (GDH) in hepatic mitochondria, releasing free ammonia and regenerating α-ketoglutarate. GDH activity is allosterically regulated by ADP and GTP, linking nitrogen disposal to cellular energy status. Glutamine synthetase and glutaminase establish a parallel axis: glutamine serves as a non-toxic ammonia carrier in the circulation and as a major nitrogen donor for nucleotide and hexosamine biosynthesis.

The urea cycle and detoxification of ammonia

Free ammonia is neurotoxic and is detoxified through the urea cycle, compartmentalized between hepatic mitochondria and cytosol. Carbamoyl phosphate synthetase 1 (CPS1) condenses ammonia with bicarbonate, initiating a series of reactions involving ornithine, citrulline, argininosuccinate, and arginine that culminate in urea release and ornithine regeneration. N-acetylglutamate, synthesized in response to elevated arginine, allosterically activates CPS1 and links cycle flux to dietary nitrogen load.⁶

Defects in any urea cycle enzyme produce hyperammonemia, with neurological consequences driven by glutamine accumulation in astrocytes and disruption of neurotransmitter balance.

Carbon skeleton disposal and integration with central metabolism

After deamination, amino acid carbon skeletons enter central metabolism at seven defined points: pyruvate, acetyl-CoA, acetoacetyl-CoA, α-ketoglutarate, succinyl-CoA, fumarate, and oxaloacetate. This convergence enables amino acids to support gluconeogenesis during fasting, fuel oxidative phosphorylation, or contribute to lipogenesis in the fed state.⁷

The branched-chain amino acids (BCAAs), leucine, isoleucine, and valine, exemplify tissue-specific catabolism. Their initial transamination occurs predominantly in skeletal muscle, while subsequent oxidative decarboxylation by the branched-chain α-ketoacid dehydrogenase (BCKDH) complex proceeds mainly in liver and other oxidative tissues. BCKDH is regulated by phosphorylation, paralleling the pyruvate dehydrogenase complex, and its dysregulation has been mechanistically linked to insulin resistance through accumulation of BCAA-derived metabolites.⁸

Biosynthetic roles beyond protein synthesis

One-carbon metabolism

Serine, glycine, and methionine drive one-carbon metabolism, a network that channels methyl and formyl groups through tetrahydrofolate (THF) and S-adenosylmethionine (SAM) for nucleotide synthesis, methylation reactions, and redox homeostasis. Serine hydroxymethyltransferase (SHMT) converts serine to glycine while loading carbon onto THF, supplying units for thymidylate and purine synthesis. The methionine cycle regenerates SAM, the universal methyl donor for DNA, RNA, protein, and lipid methylation.⁹

Glutathione and redox defense

Cysteine, glutamate, and glycine combine to form glutathione (GSH), the principal intracellular thiol antioxidant. Cysteine availability is typically rate-limiting and is sustained by the transsulfuration pathway, which derives cysteine from methionine via homocysteine. This pathway links amino acid metabolism to redox status, and its disruption contributes to oxidative stress in hepatic, vascular, and neurological disease.

Neurotransmitters and signaling molecules

Several amino acids serve as direct neurotransmitter precursors. Glutamate is the principal excitatory neurotransmitter and the precursor of GABA via glutamate decarboxylase. Tyrosine, derived from phenylalanine through phenylalanine hydroxylase, yields dopamine, norepinephrine, and epinephrine. Tryptophan generates serotonin and, through the kynurenine pathway, immunomodulatory metabolites that influence neuroinflammation and tumor immunity.¹⁰

How is amino acid metabolism regulated at the cellular level?

Amino acid sufficiency is sensed by mechanistic Target Of Rapamycin Complex 1 (mTORC1), which integrates signals from leucine, arginine, and methionine through the Rag GTPase system at the lysosomal surface. When amino acids are abundant, mTORC1 promotes protein synthesis, nucleotide production, and lipogenesis while suppressing autophagy. Amino acid scarcity, conversely, activates general control nonderepressible 2 (GCN2), which phosphorylates eIF2α to attenuate global translation while inducing the integrated stress response (ISR) transcriptional program through ATF4.¹¹

These two pathways operate antagonistically to match anabolic activity with substrate availability. ATF4 induces transcription of amino acid transporters, biosynthetic enzymes, and aminoacyl-tRNA synthetases, restoring intracellular pools. The mTORC1–GCN2 axis therefore couples amino acid sensing to the broader programs of growth, stress adaptation, and proteostasis.

How does amino acid metabolism support disease states?

In proliferating cells, amino acids supply nitrogen for nucleotide synthesis, carbon for biomass, and reducing equivalents for redox balance. Cancer cells frequently exhibit glutamine dependence, using glutaminolysis to replenish TCA cycle intermediates (anaplerosis) and to generate aspartate for nucleotide synthesis. Serine and glycine pathways are upregulated to feed one-carbon metabolism, supporting methylation and nucleotide demand during rapid proliferation.¹²

Immune cell function is similarly shaped by amino acid availability. Arginine metabolism polarizes macrophage states, while tryptophan catabolism through indoleamine 2,3-dioxygenase (IDO) modulates T cell responses. In metabolic disease, elevated circulating BCAAs and aromatic amino acids correlate with insulin resistance, reflecting impaired catabolic flux and altered nitrogen handling.

What determines whether an amino acid becomes limiting?

Amino acid availability depends on dietary intake, endogenous synthesis capacity, transporter expression, and competing demands across tissues. Essential amino acids are inherently constrained by intake, while conditionally essential amino acids become limiting when synthetic capacity is overwhelmed by demand; for example, glutamine during critical illness or arginine during rapid growth and immune activation.

Tissue-specific transporter expression establishes selective uptake hierarchies. LAT1 (SLC7A5) imports large neutral amino acids in exchange for glutamine, coupling intracellular glutamine pools to leucine-driven mTORC1 activation. This transporter-level regulation explains how systemic amino acid balance is translated into cell-autonomous signaling and growth decisions.

Key nodes in amino acid metabolism

This framework highlights how a limited set of regulatory nodes governs the integration of amino acid metabolism with whole-body physiology.

Frequently asked questions

Why is glutamine considered a central currency of nitrogen metabolism?

Glutamine carries two nitrogen atoms, one as an α-amino group and one as an amide. This makes it the most abundant amino acid in plasma and the principal interorgan nitrogen shuttle. It donates nitrogen for nucleotide, hexosamine, and asparagine synthesis, and its carbon skeleton replenishes the TCA cycle through glutaminolysis, linking nitrogen and energy metabolism.

How do inborn errors of amino acid metabolism produce disease?

Inborn errors typically result from loss-of-function variants in enzymes catalyzing key catabolic or biosynthetic steps. The resulting accumulation of upstream substrates or depletion of downstream products produces tissue-specific toxicity; for example, phenylalanine accumulation in phenylketonuria disrupts neurodevelopment, while branched-chain α-ketoacid accumulation in maple syrup urine disease causes neurological injury.

Why are amino acids increasingly viewed as signaling molecules rather than only substrates?

Amino acids directly engage sensors such as mTORC1, GCN2, and nutrient-responsive transcription factors that reprogram cellular metabolism, growth, and stress responses. Their signaling roles operate independently of bulk incorporation into protein, explaining why localized changes in specific amino acid pools can drive disproportionate effects on cell fate and function.

References

1. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37(1):1–17.
2. DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200.
3. Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52(1):15–30.
4. Reeds PJ. Dispensable and indispensable amino acids for humans. J Nutr. 2000;130(7):1835S–1840S.
5. Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R. Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem Funct. 2003;21(1):1–9.
6. Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. J Inherit Metab Dis. 2019;42(6):1192–1230.
7. Berg JM, Tymoczko JL, Gatto GJ, Stryer L. Biochemistry. 9th ed. W.H. Freeman; 2019.
8. Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10(12):723–736.
9. Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25(1):27–42.
10. Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science. 2017;357(6349):eaaf9794.
11. Wolfson RL, Sabatini DM. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 2017;26(2):301–309.
12. Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168(4):657–669.